Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05631548 · ClinicalTrials.gov registry record · NA

Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder (Pilot Study)

A NA study of Cocaine Use Disorder, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT05631548 is a NA study of Cocaine Use Disorder that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 6 participants, below the 104-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05631548, a NA study of Cocaine Use Disorder, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the effects of active intermittent theta burst stimulation (iTBS) to dorsomedial prefrontal cortex (dmPFC) on electroencephalogram (EEG) measures of reward sensitivity and cue reactivity and cocaine craving in cocaine users

Conditions Studied

Interventions

  • DEVICE Sham iTBS
  • DEVICE iTBS to dmPFC

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2023-02-23
Est. Completion 2023-08-02
Phase NA

What the Registry Record Tells You About NCT05631548

The ClinicalTrials.gov registry entry for NCT05631548 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 104-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (94% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cocaine Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Sham iTBS is the first listed.

NCT05631548 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05631548 about?

NCT05631548 is a clinical study titled "Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder (Pilot Study)". The purpose of this study is to assess the effects of active intermittent theta burst stimulation (iTBS) to dorsomedial prefrontal cortex (dmPFC) on electroencephalogram (EEG) measures of reward sensitivity and cue reactivity and cocaine craving in cocaine users

What is the current status of trial NCT05631548?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2023-02-23. Estimated completion is 2023-08-02.

What conditions does trial NCT05631548 study?

This clinical trial studies the following conditions: Cocaine Use Disorder.

What interventions are being tested in trial NCT05631548?

The interventions under investigation include: Sham iTBS (DEVICE), iTBS to dmPFC (DEVICE).

Who is sponsoring clinical trial NCT05631548?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05631548 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cocaine Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.